A randomised comparison evaluating changes in bone mineral density in advanced prostate cancer: luteinising hormone-releasing hormone agonists versus transdermal oestradiol. - Langley, RE; Kynaston, HG; Alhasso, AA; Duong, T; Paez, EM; Jovic, G; Scrase, CD; Robertson, A; Cafferty, F; Welland, A; Carpenter, R; Honeyfield, L; et al. (European Urology, 2015)